Early Diagnosis and Nutritional Treatment Stabilizes Neuropsychiatric Disorders

Ian James Martins

Authors

Ian James Martins

Keywords:

neuropsychiatric; schizophrenia; depression; bipolar disease; diagnosis; mitophagy; endoplasmic reticulum stress

Abstract

The reliable diagnostic identification of neuropsychiatric disorders such as schizophrenia, bipolar disease, and depression has been associated with some biological markers (genomics, proteomics, metabolomics) but to date, these markers do not have the sensitivity/specificity of a diagnostic test. Biomarker tests that are relevant to global chronic disease are now applicable to neuropsychiatric diseases to prevent autoimmune disease, endoplasmic reticulum stress associated mitophagy with relevance to neuron apoptosis. Metabolic abnormalities has been linked to neuropsychiatric disorder with the careful nutritional assessment of patients reported in many published studies. Early interventions with genomic medicine now assist in the prevention of autoimmune disease associated with global chronic disease and neuropsychiatric disorders.

Downloads

How to Cite

Early Diagnosis and Nutritional Treatment Stabilizes Neuropsychiatric Disorders. (2018). Global Journal of Medical Research, 18(45), 1-7. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

Author Biography

Ian James Martins

Nobel Scientist Award 2026, Nobel Research Award 2024 (Scientific Laurels), Life Journey and career: Video Program: Live platform: https://youtu.be/cYy4OmTkKvY?t=21, Eminent Scientist Award (INSO 2023), Excellence Service Award (INSO 2023), Outstanding Scientist Award 2022, (INSO AWARDS), International Scientist Lifetime Achievement Award 2022 (INSO AWARDS), Distinguished Scientist Award in "International Scientist Awards on Engineering, Science and Medicine", (2021), Dr Martins is now in the top 30 INTERNATIONAL FELLOWS of history (https://sites.google.com/site/internationalindexing/advisory-board). Dr Martins is a WORLD CHAMPION and has World Records to his credit in Endocrinology & Metabolism, Diabetes and Nutrition, Dr.Med, DSc (Honoris Causa) Doctrin De Science Award Honoris Causa), Top Scholar (Scholar GPS, 0.5%), AD Scientific Index Rankings for Scientist, 139201 from 1037828. Editor/Reveiwer for Open Acess Pub/MDPI and Scientific Reports (Nature) journals and other journals. Dr Martins has reveiwed approx. 6450 INVITED articles over past 8 years. Advisory Board Member for Photon Journal. Chief Editor for Biomedical and Pharmacology, Chief Editor for Journal of Neuroscience and Neurological Surgery, Chief Editor for International Journal of Diabetes Research (2014-2021), Research and Reviews: Neuroscience(2016-2021) and Journal of Diabetes and Clinical Studies (2017-2021),Advancement in Case Studies (2020-2023), American Journal of Biomedical Science and Research (2023), Global Journal of Endocrinology and Metabolism (2020-2023), Interventions in Obesity and Diabetes (2020-2023), Journal of Spine and Neuroscience, Innovations in Molecular Biotechnology, Journal of Metabolic Syndrome and Journal of Diabetes, Obesity and Metabolism, Journal of Diabetes Research and Management. BIT Member (BIT Congress. Inc) with an h-index of >302. Google Scholar (42),ResearchGate (41) with RESEARCH INTEREST SCORE in Nutrition and Dietetics (> 97 %) of all RESEARCHGATE MEMBERS > 2967, > 76600 reads, 76 mentions, 362 Recommendations. Scopus Mendeley (29), UWA Research Repository (25), Semantic Scholar (34), OpenAlex (32), Web of Science Researcher ID AAC-3215-2020 (27) Top Peer Reveiwer, 515 verified reveiws and 105 editor records. Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu (>18213 veiws, >2680 citations) 0.5% CUP. Postdoctoral Researcher Frontiers in Genetics (14,463 veiws/downloads, 1527 citations),105 Editorial Contributions, Dimensions (1909 citations),AD Scientific Index Ranking (>5223 citations (h=39), Scholar GPS (33) . The citations past 25 years >40000. Editorial Board Member for 150 journals. Semantic Scholar profile with 133 highly influential citations from 204 PUBLICATIONS, ECU RESEARCH ONLINE (>13942) downloads across 52 papers). Scientific Research Publishing articles (46445 downloads, 72450 veiws, 294 citations). Winner (World Academic Championship -2017) in Diabetes and Medical Science (Nutrition). 1790 INTERNATIONAL Certificates from conferences, congresses, summits and journals. Keynote addresses at International Conference on Biomedicine and Pharmacotherapy 2018, Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome 2018, Immunology World 2018, Laboratory Medicine 2018, Innovate Pharma 2017, Innovate Neurology 2017, World Diabetes and Endocrinology Summit-2017 and Pharmacology and Ethnopharmacology 2016. Chair Sessions on International Conference on Biomedicine and Pharmacotherapy 2018, Global Experts Meeting on Diabetes, Hypertension and Metabolic Syndrome 2018, Laboratory management, Cytogenetics, Clinical Microbiology, Diagnostic Laboratory Medicine, 13th Interantional Conference on Laboratory Medicine and Pathology, Berlin, Germany, June 25-26, 2018, Chairing Sessions on Vaccinology, Immunopathology, Immunotherapy, Immune Proteomics, Cancer and Tumour Oncology, 7th World Congress on Immunology, Amsterdam, Netherlands, April 19-20, 2018, Chair, Biotherapeutics for Diseases, Bit's 2nd International Congress of Biotherapy-2018 (Committee Member), Chair, Innovate Conferences 2017, Chair/Co-Chair at congress World Gene Convention-2016 (Shanghai, China, Pharmacology and Ethanopharmacology 2016 (Chicago, USA), Annual World Congress of Diabetes-2014 (Haikou, China), World Gene Convention-2014 (Haikou, China). Reveiwer/Editor 200 journals. > 700 IMPORTANT PUBLICATION ACHIEVEMENTS TWEET:Twitter https://twitter.com/IanJamesMartin2. Invited Organizing committee member for 200 conferences around the world (2020-2024) BLOOD TEST critical to COVID-19, diabetes and neurodegenerative disease. Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions. ECPT 6.4 (2018): 209-215. The Scientific News, Advances in Treating Diseases. November Edition, 2018. Annie B. Coulter

References

Taber H, Hurley A, Yudofsky C (2010) Diagnosis and Treatment of Neuropsychiatric Disorders. 61, 121-133.

I. Martins (2015) Diabetes and Organ Dysfunction in the Developing and Developed World. 15(3), 15-21. https://doi.org/10.1111/dewb.2015.15.issue-3

I. Martins (2018) Genomic medicine and acute cardiovascular disease progression in diabetes. 2, 1-003.

Kota K, Jammula Meher L. K, S, Krishna S.V.S, et Kota S. K (2012) Neuropsychiatric screening in type 2 diabetes mellitus. 16(7), 37. https://doi.org/10.4103/2230-8210.94255

Yatan Balhara (2011) Diabetes and psychiatric disorders.Indian J Endocrinol Metab. 15(4), 274-283. https://doi.org/10.4103/2230-8210.85579

Levitt E., Swami S., Abraham M., Murphy M., A. Jawad (2005) Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. 6, 84-9.

I. Martins (2018) Genomic Medicine and Endocrine Autoimmunity as Key to Mitochondrial Disease. 2, 1-3.

D. Kerr, Krishnan C, Carmen Pucak M. L (2005) The immune system and neuropsychiatric diseases. 17, 443-449.

Aarane Ratnaseelan, Irene Tsilioni, Theoharis Theoharides (2018) Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. 40(6), 903-917. https://doi.org/10.1016/j.clinthera.2018.05.004

Gerwyn Morris, Michael Berk (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. 13(1), 68. https://doi.org/10.1186/s12916-015-0310-y

Franziska Radtke, Gareth Chapman, Jeremy Hall, Yasir Syed (2017) Modulating Neuroinflammation to Treat Neuropsychiatric Disorders. 2017, 1-21. https://doi.org/10.1155/2017/5071786

David Horrobin, A. Glen, Krishna Vaddadi (1994) The membrane hypothesis of schizophrenia. 13(3), 195-207. https://doi.org/10.1016/0920-9964(94)90043-4

E. Schaeffer, W. Gattaz, G. Eckert (2012) Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2. 12, 2314-2323.

I. Martins (2018) Increased Risk for Obesity and Diabetes with Neurodegeneration in Developing Countries. Top 10 Contribution on Genetics. 1, 1-35. http://www.avid.science.com

Shivangi Patel, Dilip Sharma, Kiran Kalia, Vinod Tiwari (2017) Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches. 83, 589-603. https://doi.org/10.1016/j.neubiorev.2017.08.025

Neil Sprenkle, Savannah Sims, Cristina Sánchez, Gordon Meares (2017) Endoplasmic reticulum stress and inflammation in the central nervous system. 12(1), 42. https://doi.org/10.1186/s13024-017-0183-y

Dan Lindholm, Laura Korhonen, Ove Eriksson, Sulev Kõks (2017) Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease. 5, 48. https://doi.org/10.3389/fcell.2017.00048

Douglas Wallace (2017) A Mitochondrial Etiology of Neuropsychiatric Disorders. 74(9), 863. https://doi.org/10.1001/jamapsychiatry.2017.0397

Marin E, Saneto P (2016) Neuropsychiatric Features in Primary Mitochondrial Disease. 34, 247-294.

Liming Pei, Douglas Wallace (2018) Mitochondrial Etiology of Neuropsychiatric Disorders. 83(9), 722-730. https://doi.org/10.1016/j.biopsych.2017.11.018

Baroni Marazziti D, Landi Picchetti M, Silvestri P, et al (2011) Mitochondrial Alterations and Neuropsychiatric Disorders. 18, 4715-4721.

Erin Heinzen, Benjamin Neale, Stephen Traynelis, Andrew Allen, David Goldstein (2015) The Genetics of Neuropsychiatric Diseases: Looking In and Beyond the Exome. 38(1), 47-68. https://doi.org/10.1146/annurev-neuro-071714-034136

A. Corvin, G. Donohoe, A. Hargreaves, L. Gallagher, M. Gill (2012) The Cognitive Genetics of Neuropsychiatric Disorders. 12, 579-613. https://doi.org/10.1007/7854_2011_188

Danielle Dick, Brien Riley, Kenneth Kendler (2010) Nature and nurture in neuropsychiatric genetics: where do we stand?. 12(1), 7-23.

Ian Martins (2016) Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. 05(01), 9-26. https://doi.org/10.4236/aar.2016.51002

Ian Martins (2017) Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome. 03(03), 24.

Carolyn Ptak, Arturas Petronis (2010) Epigenetic approaches to psychiatric disorders. 12(1), 25-35.

Mahgoub M, Monteggia M (2013) Epigenetics and Psychiatry. 10, 734-741.

Fukuo Kishi T, Okochi Kitajima T, et Yamanouchi Y (2011) SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study. 10, 257-263.

Li Lu G, Zhao Zhang H, L. Yan (2018) Role and Possible Mechanisms of Sirt1 in Depression. 2018(1), 1-6. https://doi.org/10.1155/2018/8596903

Hesterman Kim H-D, Magazu Call T, Keeley al (2016) SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens. 36(32), 8441-8452. https://doi.org/10.1523/jneurosci.0212-16.2016

Snehajyoti Chatterjee, Ted Abel (2016) To Stay Happy, Keep Your SIRT1 Active. 80(11), 808-809. https://doi.org/10.1016/j.biopsych.2016.09.014

Juhyun Song, Jongpil Kim (2016) Role of Sirtuins in Linking Metabolic Syndrome with Depression. 10, 86. https://doi.org/10.3389/fncel.2016.00086

Visco-Comandini Lo Iacono L, Valzania A, Coviello Viscomi M.T, et al (2015) Adversity in childhood and depression: linked through SIRT1. 5(9), e629-e629. https://doi.org/10.1038/tp.2015.125

Uchida Abe-Higuchi N, Higuchi Yamagata H, et Hobara T (2016) Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior. 80(11), 815-826. https://doi.org/10.1016/j.biopsych.2016.01.009

Wu Bu X, Yang Lu X, et Xu X (2017) Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder. Volume 13, 1633-1645.

Herskovits Z, Guarente L (2014) SIRT1 in Neurodevelopment and Brain Senescence. 81, 471-483.

Stanley Chan, Xuechan Zhao, Abdulsalam Elfowiris, Cherubina Ratnam, Terence Herbert (2017) Herbert, T.P. The role of de novo protein synthesis and SIRT1 in ER stress-induced Atf4 and Chop mRNA expression in mammalian cells. 138, 156-167. https://doi.org/10.1016/j.biochi.2017.04.018

Jung W, Lee T, Lee W, Ka H (2012) SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. 422, 229-232.

Li Y., Xu S., Giles A., Nakamura K., Lee W. (2011) Hepatic over expression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. 25, 1664-79.

Koga T, Suico A, Shimasaki S, Watanabe E, Kai Y (2015) Endoplasmic Reticulum (ER) Stress Induces Sirtuin 1 (SIRT1) Expression via the PI3K-Akt-GSK3β Signaling Pathway and Promotes Hepatocellular Injury. 290(51), 0366-3037. https://doi.org/10.1074/jbc.m115.664169

Prola A, Piquereau Lecru L, et J (2017) SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation. 24(2), 343-356. https://doi.org/10.1038/cdd.2016.138

Ian Martins (2018) Heat Shock Gene Inactivation and Protein Aggregation with Links to Chronic Diseases. 6(2), 39. https://doi.org/10.3390/diseases6020039

I. Martins (2017) The Future of Genomic Medicine Involves the Maintenance of Sirtuin 1 in Global Populations. 2, 13.

J. MartinsI (2016) Bacterial Lipopolysaccharides Change Membrane Fluidity with Relevance to Phospholipid and Amyloid Beta Dynamics in Alzheimer's Disease.J Microb Biochem Technol. 8(4), 322-324.

Ian Martins (2015) LPS Regulates Apolipoprotein E and Aβ Interactionswith Effects on Acute Phase Proteins and Amyloidosis. 04(02), 69-77. https://doi.org/10.4236/aar.2015.42009

I. Martins (2018) Appetite Regulation and the Peripheral Sink Amyloid beta Clearance Pathway in Diabetes and Alzheimer's Disease. Top 10 Commentaries in Alzheimer's Disease. 2, 1-11. http://www.avidscience

Reichel Müller C. P, Rhein Mühle C, et Gulbins E (2015) Brain membrane lipids in major depression and anxiety disorders. 1851, 1052-1065.

P. Kidd (2004) Bipolar disorder and cell membrane dysfunction. Progress toward integrative management. 9, 107-135.

Martins J (2015) Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases. 16, 9554-2957.

Karatinos J, Rosse B, Deutsch I (1995) The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders. 18, 482-499.

O. Akyol, S. Zoroglu, F. Armutcu, S. Sahin, A. Gurel (2004) Nitric oxide as a physiopathological factor in neuropsychiatric disorders. 18, 377-390.

I. Martins (2017) Antimicrobial activity inactivation and toxic immune reactions induce Epilepsy in human. 2, 1-7.

I. Martins (2015) Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimer's disease. 1-48.

Harvey D, Heaton K, Carpenter T, Green F, et Gold J. M (2012) Diagnosis of schizophrenia: Consistency across information sources and stability of the condition. 140(1-3), 9-14. https://doi.org/10.1016/j.schres.2012.03.026

Assen Jablensky (2010) The diagnostic concept of schizophrenia: its history, evolution, and future prospects. 12(3), 271-287.

Larry Goldman, Nancy Nielsen, Hunter Champion (1999) Awareness, diagnosis, and treatment of depression. 14(9), 569-580. https://doi.org/10.1046/j.1525-1497.1999.03478.x

A. Rush (1990) Problems associated with the diagnosis of depression. 15-22.

Katie Smith, Perry Renshaw, John Bilello (2013) The diagnosis of depression: current and emerging methods. 54(1), 1-6. https://doi.org/10.1016/j.comppsych.2012.06.006

Larry Culpepper (2014) The Diagnosis and Treatment of Bipolar Disorder: Decision-Making in Primary Care. 16. https://doi.org/10.4088/pcc.13r01609

I. Martins (2018) Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions. 6(4), 209-215.

Ian Martins (2016) Magnesium Therapy Prevents Senescence with the Reversal of Diabetes and Alzheimer's Disease. 08(07), 694-710. https://doi.org/10.4236/health.2016.87073

I. Martins (2017) Nutrition Therapy Regulates Caffeine Metabolism with Relevance to NAFLD and Induction of Type 3 Diabetes. 4(1), 1-9.

Sweers Tessier C, Bergaoui Frajerman A, et Ferreri F (2016) Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations. 6(10), e906-e906. https://doi.org/10.1038/tp.2016.142

I. Martins (2017) The Future of Biomarkers Tests and Genomic Medicine in Global Organ Disease. 1, 1-6.

I. Martins (2017) Biomarker Tests and Ageing Science. 1(1), 1-2.

Strassnig M, Brar S, Ganguli R (2005) Dietary Intake of Patients with Schizophrenia. 2, 31-35.

Dipasquale S, Dazzan Pariante C. M, McGuire Aguglia E, et al (2013) The dietary pattern of patients with schizophrenia: A systematic review. 47(2), 197-207. https://doi.org/10.1016/j.jpsychires.2012.10.005

Bryan Kraft, Eric Westman (2009) Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. 6(1), 10. https://doi.org/10.1186/1743-7075-6-10

Sathyanarayana Rao, T. Asha, M. Ramesh, B., Jagannatha Rao, K. (2008) Understanding nutrition, depression and mental illnesses. 50, 77-82.

Martins J (2017) Functional Foods and Active molecules with relevance to Health and Chronic disease. 7, 833-836.

I. Martins (2015) Unhealthy Nutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities. 09(01), 1-8.